Antibody Drug Conjugate Therapeutics Market Share is witnessing significant expansion as targeted cancer therapies continue to reshape modern oncology treatment approaches. Increasing demand for precision medicine and improved clinical outcomes is encouraging pharmaceutical companies to invest heavily in advanced antibody drug conjugate (ADC) technologies. The Antibody Drug Conjugate...